Levels of Systemic Inflammatory Markers in Women with Cervical Cancer Undergoing Definitive Chemoradiotherapy Depend Primarily onPre-treatment and Post-teletherapy Tumor Volume, Rather than on the Prescribed Radiation Dose
NLR, PLR, and LMR undergo significant changes during dCRT, largely reflecting tumor burden rather than treatment parameters, supporting their role as dynamic biomarkers in CC.
Authors
- Beniamin Oskar Grabarek
- Elżbieta Pluta (ORCID: https://orcid.org/0000-0002-6588-8093)
- Elżbieta Cipora (ORCID: https://orcid.org/0000-0002-7794-550X)
- Aleksandra Czerw (ORCID: https://orcid.org/0000-0002-6189-6678)
- Krzysztof Bereza
- Tomasz Banaś
- Katarzyna Sigit
Institutions
- Jagiellonian University (PL)
- Maria Curie-Skłodowska University (PL)
- Medical University of Warsaw (PL)
- Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy (PL)
- National Institute of Oncology (HU)
- WSB University (PL)
- The Maria Sklodowska-Curie National Research Institute of Oncology (PL)
Publication Details
- Journal
- Current Pharmaceutical Biotechnology
- Published
- 2026-01-06
- DOI
- https://doi.org/10.2174/0113892010413911251122074226
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00